459 is the total number of securities HealthCor Management, L.P. has owned. The longest HealthCor Management, L.P. has owned a single stock is 27 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| HCA | HCA HOLDINGS INC | 13 | 1 | 0.05% | 2.27% | 6.17% | Q2 2013 | Q1 2022 | 27 |
| ZBH | ZIMMER HLDGS INC | 9 | 1 | 0.29% | 4.56% | 9.26% | Q3 2013 | Q2 2022 | 26 |
| DHR | DANAHER CORPORATION | 13 | 2 | 0.25% | 2.65% | 5.60% | Q2 2014 | Q3 2022 | 26 |
| NBIX | NEUROCRINE BIOSCIENCES... | 17 | 1 | 0.15% | 2.65% | 7.77% | Q3 2015 | Q4 2022 | 26 |
| UNH | UNITEDHEALTH GROUP INC | 17 | 1 | 0.06% | 2.67% | 6.38% | Q2 2014 | Q3 2022 | 24 |
| VRTX | VERTEX PHARMACEUTICALS... | 12 | 1 | 0.18% | 2.55% | 5.32% | Q2 2013 | Q3 2021 | 24 |
| HUM | HUMANA INC | 11 | 1 | 0.58% | 2.44% | 6.64% | Q2 2013 | Q3 2022 | 22 |
| BMY | BRISTOL-MYERS SQUIBB CO | 7 | 1 | 0.30% | 2.26% | 9.15% | Q1 2016 | Q3 2022 | 22 |
| BIIB | BIOGEN INC | 8 | 1 | 0.09% | 3.10% | 8.48% | Q2 2013 | Q3 2022 | 21 |
| LH | LABORATORY CORP AMER H... | 16 | 4 | 2.14% | 5.40% | 8.34% | Q4 2014 | Q2 2020 | 20 |
| ISRG | INTUITIVE SURGICAL INC | 10 | 1 | 0.88% | 3.41% | 6.27% | Q2 2013 | Q4 2022 | 20 |
| MRK | MERCK & CO INC NEW | 10 | 1 | 0.35% | 3.26% | 8.06% | Q4 2013 | Q2 2020 | 20 |
| MDT | MEDTRONIC PLC | 20 | 20 | 0.17% | 3.17% | 8.62% | Q1 2017 | Q4 2021 | 20 |
| BSX | BOSTON SCIENTIFIC CORP | 10 | 2 | 0.30% | 2.30% | 6.77% | Q4 2014 | Q3 2022 | 19 |
| PCRX | PACIRA PHARMACEUTICALS... | 12 | 1 | 0.07% | 1.94% | 4.16% | Q4 2014 | Q1 2022 | 18 |
| CVRS | CORINDUS VASCULAR ROBO... | 18 | 18 | 0.52% | 1.63% | 3.90% | Q2 2015 | Q3 2019 | 18 |
| EW | EDWARDS LIFESCIENCES CORP | 7 | 1 | 0.46% | 3.76% | 8.16% | Q3 2013 | Q4 2020 | 17 |
| ALXN | ALEXION PHARMACEUTICAL... | 7 | 1 | 0.16% | 2.35% | 5.28% | Q2 2013 | Q4 2020 | 17 |
| THC | TENET HEALTHCARE CORP | 6 | 1 | 0.08% | 1.64% | 3.48% | Q2 2013 | Q3 2022 | 17 |
| DXCM | DEXCOM INC | 5 | 2 | 0.12% | 4.24% | 33.35% | Q2 2015 | Q4 2022 | 16 |
| MCK | MCKESSON CORP | 8 | 1 | 0.68% | 2.40% | 5.88% | Q3 2013 | Q3 2022 | 16 |
| LIVN | LIVANOVA PLC | 7 | 1 | 0.42% | 2.32% | 4.34% | Q2 2017 | Q3 2022 | 16 |
| CLVS | CLOVIS ONCOLOGY INC | 9 | 3 | 0.22% | 1.40% | 3.24% | Q2 2013 | Q3 2019 | 16 |
| HAE | HAEMONETICS CORP MASS | 7 | 2 | 0.58% | 2.53% | 6.13% | Q4 2016 | Q1 2021 | 15 |
| INCY | INCYTE CORP | 5 | 1 | 0.07% | 1.87% | 4.20% | Q2 2013 | Q3 2022 | 15 |
| TMO | THERMO FISHER SCIENTIF... | 4 | 1 | 0.15% | 1.67% | 3.69% | Q3 2013 | Q3 2022 | 15 |
| ABBV | ABBVIE INC | 5 | 1 | 0.68% | 2.80% | 5.42% | Q3 2013 | Q3 2022 | 14 |
| NVRO | NEVRO CORP | 9 | 1 | 0.19% | 2.75% | 7.49% | Q1 2016 | Q3 2022 | 14 |
| GILD | GILEAD SCIENCES INC | 5 | 1 | 0.32% | 2.39% | 6.57% | Q2 2013 | Q4 2019 | 14 |
| UHS | UNIVERSAL HLTH SVCS INC | 8 | 1 | 0.11% | 2.15% | 4.42% | Q3 2014 | Q2 2022 | 14 |
| ABT | ABBOTT LABS | 4 | 1 | 0.23% | 2.06% | 5.09% | Q4 2013 | Q3 2022 | 14 |
| HZNP | HORIZON THERAPEUTICS P... | 11 | 2 | 0.93% | 4.15% | 7.24% | Q2 2019 | Q3 2022 | 13 |
| MNKKQ | MALLINCKRODT PUB LTD CO | 6 | 1 | 0.21% | 4.52% | 8.33% | Q1 2014 | Q4 2017 | 12 |
| CELG | CELGENE CORP | 10 | 1 | 0.88% | 4.12% | 9.81% | Q4 2014 | Q4 2018 | 12 |
| IQV | IQVIA HLDGS INC | 10 | 2 | 1.55% | 2.77% | 5.55% | Q4 2017 | Q1 2021 | 12 |
| SYK | STRYKER CORPORATION | 4 | 1 | 0.27% | 1.70% | 5.16% | Q4 2017 | Q1 2022 | 12 |
| NTRA | NATERA INC | 6 | 6 | 0.16% | 1.69% | 4.32% | Q3 2015 | Q3 2022 | 12 |
| ACAD | ACADIA PHARMACEUTICALS... | 5 | 1 | 0.12% | 1.26% | 4.03% | Q1 2014 | Q1 2021 | 12 |
| ZTS | ZOETIS INC | 4 | 1 | 0.02% | 1.10% | 2.35% | Q3 2013 | Q3 2021 | 12 |
| BMRN | BIOMARIN PHARMACEUTICA... | 5 | 1 | 0.04% | 5.74% | 34.88% | Q2 2015 | Q4 2022 | 11 |
| AET | AETNA INC NEW | 4 | 1 | 0.81% | 4.72% | 9.22% | Q3 2013 | Q3 2017 | 11 |
| REGN | REGENERON PHARMACEUTICALS | 5 | 1 | 0.45% | 4.10% | 7.32% | Q4 2017 | Q1 2022 | 11 |
| MDGL | MADRIGAL PHARMACEUTICA... | 11 | 11 | 1.75% | 3.69% | 5.68% | Q2 2018 | Q4 2020 | 11 |
| HOLX | HOLOGIC INC | 3 | 1 | 0.44% | 2.74% | 7.55% | Q2 2016 | Q3 2022 | 11 |
| A | AGILENT TECHNOLOGIES INC | 7 | 1 | 0.55% | 2.36% | 5.14% | Q3 2013 | Q3 2022 | 11 |
| CNC | CENTENE CORP DEL | 5 | 1 | 0.51% | 2.21% | 4.60% | Q1 2014 | Q3 2022 | 11 |
| BDX | BECTON DICKINSON & CO | 3 | 1 | 0.21% | 1.79% | 6.08% | Q1 2014 | Q3 2022 | 11 |
| MDVN | MEDIVATION INC | 9 | 1 | 1.93% | 3.87% | 6.75% | Q2 2013 | Q1 2016 | 10 |
| AGN | ALLERGAN PLC | 6 | 1 | 0.35% | 2.82% | 7.27% | Q2 2015 | Q1 2019 | 10 |
| ABC | AMERISOURCEBERGEN CORP | 7 | 1 | 0.84% | 2.67% | 4.62% | Q4 2015 | Q3 2022 | 10 |
| ANTM | ELEVANCE HEALTH INC | 4 | 1 | 1.16% | 2.48% | 5.10% | Q4 2017 | Q3 2022 | 10 |
| CVS | CVS HEALTH CORP | 2 | 1 | 0.21% | 2.37% | 4.77% | Q1 2015 | Q3 2022 | 10 |
| PFE | PFIZER INC | 3 | 1 | 0.30% | 2.08% | 5.59% | Q3 2013 | Q1 2022 | 10 |
| NUVA | NUVASIVE INC | 7 | 1 | 0.56% | 1.68% | 2.59% | Q2 2013 | Q2 2020 | 10 |
| SNDX | SYNDAX PHARMACEUTICALS... | 10 | 10 | 0.02% | 1.30% | 2.58% | Q3 2020 | Q4 2022 | 10 |
| ALGN | ALIGN TECHNOLOGY INC | 3 | 1 | 0.03% | 1.21% | 2.90% | Q4 2015 | Q3 2021 | 10 |
| NVST | ENVISTA HOLDINGS CORPO... | 6 | 3 | 0.32% | 2.27% | 4.06% | Q3 2019 | Q1 2022 | 9 |
| DGX | QUEST DIAGNOSTICS INC | 6 | 2 | 0.36% | 3.50% | 7.49% | Q4 2015 | Q3 2018 | 8 |
| BCR | BARD C R INC | 5 | 3 | 0.87% | 3.43% | 8.05% | Q1 2015 | Q1 2017 | 8 |
| BKD | BROOKDALE SR LIVING INC | 8 | 8 | 0.54% | 2.16% | 4.98% | Q1 2014 | Q4 2015 | 8 |
| CYTK | CYTOKINETICS INC | 8 | 8 | 0.23% | 2.01% | 6.90% | Q1 2021 | Q4 2022 | 8 |
| XENT | INTERSECT ENT INC | 8 | 8 | 0.62% | 1.98% | 3.34% | Q1 2018 | Q4 2019 | 8 |
| COO | COOPER COS INC | 3 | 2 | 0.06% | 1.96% | 4.84% | Q2 2013 | Q2 2022 | 8 |
| CNMD | CONMED CORP | 5 | 1 | 0.43% | 1.50% | 2.23% | Q1 2019 | Q4 2022 | 8 |
| AMGN | AMGEN INC | 2 | 1 | 0.02% | 1.43% | 2.56% | Q4 2015 | Q3 2022 | 8 |
| TEVA | TEVA PHARMACEUTICAL IN... | 3 | 1 | 0.19% | 1.39% | 3.95% | Q4 2013 | Q2 2022 | 8 |
| PTE | POLARITYTE INC | 8 | 8 | 0.03% | 0.18% | 0.46% | Q2 2018 | Q1 2020 | 8 |
| AUPH | AURINIA PHARMACEUTICAL... | 7 | 7 | 0.17% | 3.65% | 6.47% | Q3 2019 | Q1 2021 | 7 |
| LLY | LILLY ELI & CO | 2 | 1 | 0.33% | 3.33% | 6.78% | Q3 2013 | Q3 2022 | 7 |
| MYL | MYLAN INC | 7 | 7 | 1.91% | 3.32% | 6.02% | Q2 2013 | Q4 2014 | 7 |
| AKRXQ | AKORN INC | 5 | 1 | 0.49% | 2.97% | 4.53% | Q2 2013 | Q1 2017 | 7 |
| BAX | BAXTER INTL INC | 3 | 1 | 0.14% | 2.64% | 4.70% | Q4 2016 | Q3 2019 | 7 |
| WBMD | WEBMD HEALTH CORP | 7 | 7 | 0.69% | 2.31% | 3.11% | Q3 2013 | Q1 2015 | 7 |
| CI | CIGNA CORP NEW | 2 | 1 | 0.07% | 2.22% | 3.71% | Q4 2018 | Q3 2022 | 7 |
| JNJ | JOHNSON & JOHNSON | 2 | 1 | 0.05% | 2.06% | 3.58% | Q3 2017 | Q4 2021 | 7 |
| MD | MEDNAX INC | 4 | 1 | 1.06% | 1.97% | 2.62% | Q2 2017 | Q3 2020 | 7 |
| CRL | CHARLES RIV LABS INTL INC | 7 | 7 | 0.74% | 1.70% | 3.15% | Q2 2019 | Q4 2020 | 7 |
| BPMC | BLUEPRINT MEDICINES CORP | 5 | 2 | 0.86% | 1.67% | 3.20% | Q2 2019 | Q4 2022 | 7 |
| BLUE | BLUEBIRD BIO INC | 6 | 1 | 0.36% | 1.41% | 2.13% | Q1 2019 | Q3 2022 | 7 |
| SRPT | SAREPTA THERAPEUTICS INC | 4 | 1 | 0.23% | 1.41% | 2.47% | Q1 2015 | Q4 2019 | 7 |
| COLL | COLLEGIUM PHARMACEUTIC... | 7 | 7 | 0.42% | 1.19% | 1.71% | Q2 2015 | Q4 2016 | 7 |
| AFMD | AFFIMED N V | 7 | 7 | 0.44% | 0.56% | 0.82% | Q1 2021 | Q3 2022 | 7 |
| IMGN | IMMUNOGEN INC | 6 | 1 | 0.05% | 0.42% | 0.78% | Q2 2020 | Q4 2022 | 7 |
| MRUS | MERUS N V | 7 | 7 | 0.04% | 0.22% | 0.68% | Q1 2021 | Q3 2022 | 7 |
| IKNA | IKENA ONCOLOGY INC | 7 | 7 | 0.10% | 0.18% | 0.34% | Q1 2021 | Q3 2022 | 7 |
| MSACW | MEDICUS SCIENCES ACQUI... | 7 | 7 | 0.00% | 0.00% | 0.00% | Q2 2021 | Q4 2022 | 7 |
| MDRX | ALLSCRIPTS HEALTHCARE ... | 6 | 6 | 4.97% | 8.55% | 11.66% | Q2 2013 | Q3 2014 | 6 |
| T107PS | WRIGHT MED GROUP INC | 6 | 6 | 4.19% | 4.99% | 5.79% | Q2 2013 | Q3 2014 | 6 |
| CBST | CUBIST PHARMACEUTICALS... | 6 | 6 | 3.15% | 3.96% | 5.86% | Q2 2013 | Q3 2014 | 6 |
| HZNP | HORIZON PHARMA PLC | 4 | 1 | 2.13% | 3.94% | 5.60% | Q3 2014 | Q1 2019 | 6 |
| EHTH | EHEALTH INC | 5 | 1 | 0.46% | 3.39% | 4.96% | Q2 2013 | Q1 2021 | 6 |
| CI | CIGNA CORPORATION | 3 | 1 | 0.20% | 3.14% | 7.94% | Q1 2015 | Q3 2018 | 6 |
| EHC | ENCOMPASS HEALTH CORP | 3 | 1 | 0.39% | 2.69% | 4.18% | Q4 2018 | Q3 2021 | 6 |
| TFX | TELEFLEX INCORPORATED | 2 | 1 | 0.21% | 2.56% | 5.09% | Q2 2014 | Q1 2022 | 6 |
| INCR | INC RESH HLDGS INC | 5 | 1 | 0.83% | 2.20% | 3.58% | Q1 2016 | Q3 2017 | 6 |
| RDUS | RADIUS HEALTH INC | 6 | 6 | 1.18% | 2.07% | 2.96% | Q1 2018 | Q2 2019 | 6 |
| TSRO | TESARO INC | 6 | 6 | 0.82% | 1.99% | 2.53% | Q1 2014 | Q2 2015 | 6 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 3 | 1 | 0.10% | 1.81% | 2.68% | Q2 2013 | Q1 2022 | 6 |
| ICLR | ICON PLC | 3 | 1 | 1.24% | 1.79% | 2.26% | Q1 2014 | Q1 2019 | 6 |
| WELL | WELLTOWER INC | 4 | 1 | 0.28% | 1.71% | 3.10% | Q3 2015 | Q3 2021 | 6 |
| MDCO | MEDICINES CO | 5 | 1 | 0.68% | 1.44% | 3.12% | Q2 2013 | Q1 2019 | 6 |
| BCRX | BIOCRYST PHARMACEUTICA... | 6 | 6 | 0.25% | 1.42% | 2.39% | Q1 2021 | Q2 2022 | 6 |
| AERI | AERIE PHARMACEUTICALS INC | 3 | 1 | 0.08% | 1.33% | 2.82% | Q3 2014 | Q4 2019 | 6 |
| VRAY | VIEWRAY INC | 6 | 6 | 0.54% | 1.07% | 1.56% | Q3 2018 | Q4 2019 | 6 |
| NVAX | NOVAVAX INC | 6 | 6 | 0.09% | 0.46% | 1.43% | Q3 2013 | Q4 2014 | 6 |
| SPNE | SEASPINE HLDGS CORP | 6 | 6 | 0.29% | 0.44% | 0.63% | Q3 2015 | Q4 2016 | 6 |
| IDRA | IDERA PHARMACEUTICALS INC | 4 | 2 | 0.10% | 0.33% | 0.94% | Q3 2013 | Q2 2015 | 6 |
| ELOS | SYNERON MEDICAL LTD | 6 | 6 | 0.09% | 0.13% | 0.16% | Q1 2014 | Q2 2015 | 6 |
| LGVWS | LONGVIEW ACQUISITION C... | 6 | 6 | 0.00% | 0.01% | 0.02% | Q2 2021 | Q3 2022 | 6 |
| OHPAW | ORION ACQUISITION CORP | 6 | 6 | 0.00% | 0.00% | 0.01% | Q2 2021 | Q3 2022 | 6 |
| SLXP | SALIX PHARMACEUTICALS INC | 5 | 5 | 2.18% | 4.07% | 7.50% | Q4 2013 | Q4 2014 | 5 |
| SPY | SPDR S&P 500 ETF TR | 2 | 1 | 1.08% | 3.39% | 8.42% | Q3 2014 | Q1 2021 | 5 |
| WOOF | PETCO HEALTH & WELLNES... | 5 | 5 | 1.59% | 3.18% | 4.50% | Q1 2021 | Q1 2022 | 5 |
| MRVI | MARAVAI LIFESCIENCES H... | 4 | 1 | 0.47% | 1.91% | 3.39% | Q4 2020 | Q1 2022 | 5 |
| QGEN | QIAGEN NV | 2 | 1 | 0.76% | 1.68% | 2.33% | Q1 2017 | Q1 2021 | 5 |
| AEGR | AEGERION PHARMACEUTICA... | 4 | 1 | 0.07% | 1.39% | 3.66% | Q2 2013 | Q3 2014 | 5 |
| ALKS | ALKERMES PLC | 2 | 1 | 0.25% | 1.33% | 2.63% | Q2 2013 | Q4 2022 | 5 |
| VTR | VENTAS INC | 4 | 1 | 0.28% | 1.31% | 2.17% | Q3 2015 | Q3 2021 | 5 |
| AMRN | AMARIN CORP PLC | 2 | 1 | 0.07% | 1.23% | 2.29% | Q4 2018 | Q4 2020 | 5 |
| AMRI | ALBANY MOLECULAR RESH INC | 5 | 5 | 0.88% | 1.20% | 1.59% | Q1 2014 | Q1 2015 | 5 |
| RVNC | REVANCE THERAPEUTICS INC | 5 | 5 | 0.10% | 1.08% | 1.97% | Q3 2021 | Q3 2022 | 5 |
| HYPERFINE INC | 5 | 5 | 0.27% | 0.91% | 2.99% | Q4 2021 | Q4 2022 | 5 | |
| RGLS | REGULUS THERAPEUTICS INC | 5 | 5 | 0.49% | 0.66% | 0.86% | Q3 2013 | Q3 2014 | 5 |
| FPRX | FIVE PRIME THERAPEUTIC... | 2 | 1 | 0.06% | 0.65% | 1.39% | Q4 2013 | Q4 2020 | 5 |
| RACB | RESEARCH ALLIANCE CORP II | 5 | 5 | 0.36% | 0.61% | 0.86% | Q1 2021 | Q1 2022 | 5 |
| ABUS | ARBUTUS BIOPHARMA CORP | 5 | 5 | 0.42% | 0.54% | 0.74% | Q3 2015 | Q3 2016 | 5 |
| DSCI | DERMA SCIENCES INC | 5 | 5 | 0.23% | 0.40% | 0.53% | Q1 2014 | Q1 2015 | 5 |
| RAPT | RAPT THERAPEUTICS INC | 5 | 5 | 0.25% | 0.33% | 0.40% | Q2 2021 | Q2 2022 | 5 |
| CNAT | CONATUS PHARMACEUTICAL... | 5 | 5 | 0.12% | 0.19% | 0.26% | Q2 2015 | Q2 2016 | 5 |
| LPTX | LEAP THERAPEUTICS INC | 5 | 5 | 0.12% | 0.15% | 0.21% | Q3 2021 | Q3 2022 | 5 |
| EQRX INC | 5 | 5 | 0.00% | 0.01% | 0.01% | Q4 2021 | Q4 2022 | 5 | |
| EUCRW | EUCRATES BIOMEDICAL AC... | 5 | 5 | 0.00% | 0.00% | 0.00% | Q4 2021 | Q4 2022 | 5 |
| BIVV | BIOVERATIV INC | 4 | 4 | 6.58% | 10.27% | 14.06% | Q1 2017 | Q4 2017 | 4 |
| HLS | HEALTHSOUTH CORP | 4 | 4 | 2.33% | 2.96% | 4.08% | Q1 2016 | Q4 2016 | 4 |
| A | AGILENT TECHNOLOGIES INC | 3 | 1 | 1.46% | 2.78% | 4.11% | Q3 2014 | Q3 2015 | 4 |
| AGN | ALLERGAN INC | 3 | 1 | 0.36% | 2.72% | 5.57% | Q3 2013 | Q3 2014 | 4 |
| GH | GUARDANT HEALTH INC | 4 | 4 | 1.18% | 2.47% | 3.57% | Q2 2020 | Q1 2021 | 4 |
| CTRX | CATAMARAN CORP | 3 | 1 | 1.55% | 2.25% | 3.25% | Q2 2013 | Q3 2014 | 4 |
| B108PS | ACTAVIS PLC | 4 | 4 | 0.28% | 2.12% | 5.59% | Q4 2013 | Q3 2014 | 4 |
| CAH | CARDINAL HEALTH INC | 1 | 1 | 1.20% | 2.12% | 3.05% | Q4 2014 | Q1 2022 | 4 |
| RPRX | ROYALTY PHARMA PLC | 4 | 4 | 0.91% | 1.97% | 2.58% | Q2 2020 | Q1 2021 | 4 |
| VRTX | VERTEX PHARMACEUTICALS... | 2 | 2 | 1.42% | 1.91% | 2.69% | Q2 2014 | Q2 2021 | 4 |
| MOH | MOLINA HEALTHCARE INC | 3 | 1 | 1.14% | 1.89% | 2.69% | Q2 2013 | Q3 2022 | 4 |
| XLV | SELECT SECTOR SPDR TR | 2 | 1 | 0.36% | 1.67% | 3.28% | Q3 2014 | Q4 2019 | 4 |
| HRC | HILL ROM HLDGS INC | 2 | 1 | 0.36% | 1.65% | 2.53% | Q2 2016 | Q3 2018 | 4 |
| AGIO | AGIOS PHARMACEUTICALS INC | 2 | 2 | 0.62% | 1.57% | 2.80% | Q4 2019 | Q1 2021 | 4 |
| ALR | ALERE INC | 3 | 1 | 1.08% | 1.55% | 1.93% | Q1 2015 | Q1 2017 | 4 |
| HSIC | HENRY SCHEIN INC | 4 | 4 | 0.54% | 1.50% | 2.05% | Q4 2021 | Q3 2022 | 4 |
| PRAH | PRA HEALTH SCIENCES INC | 4 | 4 | 0.93% | 1.43% | 2.32% | Q1 2016 | Q4 2016 | 4 |
| RLYP | RELYPSA INC | 3 | 1 | 0.86% | 1.35% | 1.67% | Q4 2013 | Q3 2015 | 4 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 4 | 4 | 0.52% | 1.30% | 2.38% | Q2 2013 | Q1 2014 | 4 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 4 | 4 | 0.89% | 1.18% | 1.32% | Q1 2018 | Q4 2018 | 4 |
| XLV | SELECT SECTOR SPDR TR | 2 | 1 | 0.45% | 1.18% | 1.95% | Q2 2017 | Q2 2022 | 4 |
| MON | MONSANTO CO NEW | 2 | 2 | 0.45% | 1.14% | 1.82% | Q3 2013 | Q1 2017 | 4 |
| BMY | BRISTOL MYERS SQUIBB CO | 2 | 1 | 0.77% | 0.93% | 1.06% | Q2 2017 | Q3 2019 | 4 |
| VSAR | VERSARTIS INC | 4 | 4 | 0.73% | 0.89% | 1.10% | Q2 2014 | Q1 2015 | 4 |
| HALO | HALOZYME THERAPEUTICS INC | 4 | 4 | 0.23% | 0.84% | 1.18% | Q1 2021 | Q4 2021 | 4 |
| AKBA | AKEBIA THERAPEUTICS INC | 4 | 4 | 0.32% | 0.78% | 1.25% | Q2 2014 | Q1 2015 | 4 |
| ACOR | ACORDA THERAPEUTICS INC | 3 | 1 | 0.62% | 0.78% | 1.01% | Q2 2013 | Q1 2018 | 4 |
| VAR | VARIAN MED SYS INC | 2 | 1 | 0.37% | 0.78% | 1.68% | Q4 2014 | Q3 2017 | 4 |
| CANO | CANO HEALTH INC | 3 | 1 | 0.30% | 0.75% | 1.51% | Q3 2021 | Q3 2022 | 4 |
| INFI | INFINITY PHARMACEUTICA... | 4 | 4 | 0.21% | 0.59% | 0.80% | Q1 2014 | Q4 2014 | 4 |
| RCKT | ROCKET PHARMACEUTICALS... | 2 | 2 | 0.22% | 0.58% | 0.90% | Q4 2019 | Q4 2022 | 4 |
| GERN | GERON CORP | 4 | 4 | 0.08% | 0.48% | 1.11% | Q1 2022 | Q4 2022 | 4 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 3 | 1 | 0.17% | 0.33% | 0.49% | Q1 2015 | Q3 2020 | 4 |
| IRWD | IRONWOOD PHARMACEUTICA... | 2 | 2 | 0.21% | 0.30% | 0.41% | Q1 2019 | Q2 2021 | 4 |
| RTIX | RTI SURGICAL INC | 4 | 4 | 0.16% | 0.22% | 0.29% | Q3 2019 | Q2 2020 | 4 |
| CSII | CARDIOVASCULAR SYS INC... | 4 | 4 | 0.10% | 0.16% | 0.20% | Q4 2013 | Q3 2014 | 4 |
| GLPG | GALAPAGOS NV | 2 | 2 | 0.09% | 0.15% | 0.31% | Q1 2021 | Q2 2022 | 4 |
| ZSAN | ZOSANO PHARMA CORP | 4 | 4 | 0.04% | 0.07% | 0.09% | Q1 2018 | Q4 2018 | 4 |
| ARTC | ARTHROCARE CORP | 3 | 3 | 4.39% | 4.96% | 5.80% | Q2 2013 | Q4 2013 | 3 |
| RAD | RITE AID CORP | 3 | 3 | 2.18% | 3.95% | 5.04% | Q1 2015 | Q3 2015 | 3 |
| QGEN | QIAGEN NV | 3 | 3 | 2.97% | 3.76% | 4.51% | Q2 2016 | Q4 2016 | 3 |
| CFN | CAREFUSION CORP | 2 | 1 | 2.42% | 3.00% | 3.56% | Q2 2013 | Q2 2014 | 3 |
| MRK | MERCK & CO INC NEW | 1 | 1 | 1.37% | 2.36% | 3.14% | Q1 2014 | Q2 2016 | 3 |
| ILMN | ILLUMINA INC | 2 | 1 | 1.72% | 2.35% | 3.60% | Q4 2014 | Q4 2019 | 3 |
| MYL | MYLAN N V | 1 | 1 | 0.19% | 2.13% | 3.25% | Q1 2015 | Q2 2018 | 3 |
| IWM | ISHARES TR | 2 | 1 | 0.79% | 2.08% | 4.39% | Q1 2016 | Q1 2021 | 3 |
| PFE | PFIZER INC | 2 | 1 | 0.87% | 1.99% | 3.32% | Q4 2014 | Q3 2015 | 3 |
| TEVA | TEVA PHARMACEUTICAL IN... | 2 | 1 | 1.40% | 1.97% | 2.44% | Q4 2013 | Q2 2015 | 3 |
| WWAV | WHITEWAVE FOODS CO | 3 | 3 | 1.01% | 1.92% | 2.44% | Q2 2013 | Q4 2013 | 3 |
| CHNG | CHANGE HEALTHCARE INC | 3 | 3 | 1.52% | 1.71% | 1.94% | Q2 2019 | Q4 2019 | 3 |
| HYH | HALYARD HEALTH INC | 2 | 1 | 0.98% | 1.62% | 2.41% | Q4 2014 | Q1 2018 | 3 |
| CCXI | CHEMOCENTRYX INC | 3 | 3 | 0.48% | 1.60% | 2.73% | Q4 2021 | Q2 2022 | 3 |
| BIO | BIO RAD LABS INC | 1 | 1 | 0.17% | 1.40% | 3.15% | Q1 2018 | Q4 2020 | 3 |
| ZBH | ZIMMER HLDGS INC | 2 | 1 | 0.39% | 1.30% | 2.53% | Q4 2014 | Q4 2017 | 3 |
| SGNT | SAGENT PHARMACEUTICALS... | 3 | 3 | 1.08% | 1.30% | 1.69% | Q2 2015 | Q4 2015 | 3 |
| QQQ | INVESCO QQQ TR | 2 | 1 | 1.02% | 1.28% | 1.69% | Q2 2018 | Q1 2021 | 3 |
| ARNA | ARENA PHARMACEUTICALS INC | 3 | 3 | 0.78% | 1.26% | 1.73% | Q1 2020 | Q3 2020 | 3 |
| KND | KINDRED HEALTHCARE INC | 2 | 1 | 0.46% | 1.23% | 2.23% | Q1 2015 | Q4 2015 | 3 |
| THRX | THERAVANCE INC | 3 | 3 | 0.52% | 1.21% | 1.57% | Q2 2013 | Q4 2013 | 3 |
| IPXL | IMPAX LABORATORIES INC | 2 | 1 | 1.00% | 1.16% | 1.27% | Q2 2013 | Q2 2015 | 3 |
| INCY | INCYTE CORP | 2 | 1 | 0.79% | 1.13% | 1.70% | Q1 2018 | Q3 2021 | 3 |
| WMGI | WRIGHT MED GROUP N V | 3 | 3 | 0.12% | 1.08% | 1.61% | Q1 2019 | Q3 2019 | 3 |
| CERN | CERNER CORP | 2 | 1 | 0.19% | 1.06% | 1.56% | Q2 2018 | Q1 2021 | 3 |
| CELG | CELGENE CORP | 2 | 1 | 0.76% | 1.06% | 1.50% | Q1 2018 | Q4 2018 | 3 |
| SGEN | SEAGEN INC | 2 | 1 | 0.28% | 1.03% | 1.83% | Q4 2021 | Q3 2022 | 3 |
| CYNO | CYNOSURE INC | 3 | 3 | 0.89% | 1.01% | 1.21% | Q2 2013 | Q4 2013 | 3 |
| LGV | LONGVIEW ACQUISITION C... | 3 | 3 | 0.84% | 0.96% | 1.14% | Q2 2021 | Q4 2021 | 3 |
| MYOK | MYOKARDIA INC | 3 | 3 | 0.56% | 0.92% | 1.54% | Q1 2019 | Q3 2019 | 3 |
| MYGN | MYRIAD GENETICS INC | 2 | 1 | 0.07% | 0.88% | 1.76% | Q4 2013 | Q2 2018 | 3 |
| ITMN | INTERMUNE INC | 2 | 1 | 0.22% | 0.85% | 1.80% | Q2 2013 | Q2 2014 | 3 |
| MEDP | MEDPACE HLDGS INC | 3 | 3 | 0.59% | 0.81% | 0.96% | Q3 2016 | Q1 2017 | 3 |
| IDXX | IDEXX LABS INC | 3 | 3 | 0.32% | 0.68% | 0.96% | Q1 2021 | Q3 2021 | 3 |
| INSP | INSPIRE MED SYS INC | 2 | 1 | 0.22% | 0.62% | 0.85% | Q4 2021 | Q4 2022 | 3 |
| PBYI | PUMA BIOTECHNOLOGY INC | 1 | 1 | 0.47% | 0.56% | 0.68% | Q2 2014 | Q1 2018 | 3 |
| CLDX | CELLDEX THERAPEUTICS I... | 2 | 1 | 0.05% | 0.53% | 1.37% | Q2 2013 | Q4 2014 | 3 |
| SEM | SELECT MED HLDGS CORP | 3 | 3 | 0.34% | 0.49% | 0.62% | Q1 2019 | Q3 2019 | 3 |
| DCPH | DECIPHERA PHARMACEUTIC... | 2 | 1 | 0.31% | 0.48% | 0.57% | Q4 2020 | Q3 2021 | 3 |
| KYTH | KYTHERA BIOPHARMACEUTI... | 2 | 1 | 0.10% | 0.43% | 1.02% | Q2 2014 | Q1 2015 | 3 |
| BMYRT | BRISTOL-MYERS SQUIBB CO | 3 | 3 | 0.17% | 0.43% | 0.78% | Q4 2019 | Q2 2020 | 3 |
| QTRX | QUANTERIX CORP | 3 | 3 | 0.31% | 0.37% | 0.48% | Q4 2021 | Q2 2022 | 3 |
| BHVN | BIOHAVEN PHARMACTL HLD... | 2 | 1 | 0.04% | 0.28% | 0.49% | Q1 2019 | Q3 2021 | 3 |
| SNSS | SUNESIS PHARMACEUTICAL... | 3 | 3 | 0.20% | 0.23% | 0.27% | Q1 2014 | Q3 2014 | 3 |
| OHPA | ORION ACQUISITION CORP | 3 | 3 | 0.11% | 0.18% | 0.23% | Q2 2021 | Q4 2021 | 3 |
| ABGI | ABG ACQUISITION CORP I | 3 | 3 | 0.12% | 0.13% | 0.14% | Q1 2021 | Q3 2021 | 3 |
| TNDM | TANDEM DIABETES CARE INC | 3 | 3 | 0.11% | 0.12% | 0.14% | Q2 2015 | Q4 2015 | 3 |
| OMEG | OMEGA ALPHA SPAC | 3 | 3 | 0.11% | 0.12% | 0.13% | Q1 2021 | Q3 2021 | 3 |
| SRSAU | SARISSA CAPITAL ACQUIS... | 3 | 3 | 0.10% | 0.11% | 0.11% | Q1 2021 | Q3 2021 | 3 |
| EUCRU | EUCRATES BIOMEDICAL AC... | 3 | 3 | 0.10% | 0.10% | 0.12% | Q1 2021 | Q3 2021 | 3 |
| ITCI | INTRA-CELLULAR THERAPI... | 2 | 1 | 0.06% | 0.09% | 0.16% | Q4 2020 | Q2 2022 | 3 |
| JYAC | JIYA ACQUISITION CORP | 3 | 3 | 0.05% | 0.05% | 0.06% | Q1 2021 | Q3 2021 | 3 |
| BIIB | BIOGEN INC | 1 | 1 | 1.91% | 3.37% | 4.84% | Q3 2016 | Q3 2019 | 2 |
| THC | TENET HEALTHCARE CORP | 2 | 2 | 0.52% | 3.16% | 5.80% | Q1 2015 | Q2 2015 | 2 |
| GILD | GILEAD SCIENCES INC | 1 | 1 | 1.42% | 3.05% | 4.68% | Q1 2015 | Q4 2016 | 2 |
| XRAY | DENTSPLY SIRONA INC | 1 | 1 | 0.56% | 2.74% | 4.92% | Q1 2018 | Q3 2022 | 2 |
| GILD | GILEAD SCIENCES INC | 1 | 1 | 0.83% | 2.52% | 4.22% | Q3 2013 | Q2 2014 | 2 |
| BEAM | BEAM INC | 2 | 2 | 2.07% | 2.29% | 2.51% | Q3 2013 | Q4 2013 | 2 |
| ACHC | ACADIA HEALTHCARE COMP... | 2 | 2 | 2.07% | 2.20% | 2.32% | Q2 2016 | Q3 2016 | 2 |
| MASI | MASIMO CORP | 2 | 2 | 1.72% | 2.02% | 2.32% | Q1 2018 | Q2 2018 | 2 |
| DHR | DANAHER CORP DEL | 2 | 2 | 1.91% | 2.01% | 2.11% | Q4 2014 | Q1 2015 | 2 |
| OCR | OMNICARE INC | 2 | 2 | 1.12% | 1.93% | 2.74% | Q3 2014 | Q4 2014 | 2 |
| WBA | WALGREENS BOOTS ALLIAN... | 1 | 1 | 1.20% | 1.73% | 2.26% | Q2 2016 | Q2 2017 | 2 |
| OHI | OMEGA HEALTHCARE INVS INC | 1 | 1 | 1.08% | 1.70% | 2.31% | Q1 2020 | Q4 2020 | 2 |
| ARCT | ARCTURUS THERAPEUTICS ... | 2 | 2 | 0.18% | 1.46% | 2.74% | Q2 2020 | Q3 2020 | 2 |
| KZR | KEZAR LIFE SCIENCES INC | 2 | 2 | 1.01% | 1.37% | 1.73% | Q2 2022 | Q3 2022 | 2 |
| ABCO | ADVISORY BRD CO | 2 | 2 | 0.87% | 1.36% | 1.86% | Q2 2015 | Q3 2015 | 2 |
| EL | LAUDER ESTEE COS INC | 2 | 2 | 1.12% | 1.36% | 1.60% | Q3 2013 | Q4 2013 | 2 |
| NUAN | NUANCE COMMUNICATIONS INC | 1 | 1 | 1.15% | 1.32% | 1.50% | Q1 2014 | Q1 2021 | 2 |
| ALC | ALCON INC | 2 | 2 | 1.23% | 1.25% | 1.27% | Q2 2019 | Q3 2019 | 2 |
| VEEV | VEEVA SYS INC | 2 | 2 | 0.79% | 1.24% | 1.69% | Q1 2021 | Q2 2021 | 2 |
| PCYC | PHARMACYCLICS INC | 1 | 1 | 0.90% | 1.19% | 1.48% | Q3 2013 | Q1 2014 | 2 |
| PRGO | PERRIGO CO PLC | 1 | 1 | 1.11% | 1.18% | 1.26% | Q2 2015 | Q3 2016 | 2 |
| WAT | WATERS CORP | 2 | 2 | 0.73% | 1.11% | 1.48% | Q1 2016 | Q2 2016 | 2 |
| KDNY | CHINOOK THERAPEUTICS INC | 2 | 2 | 0.66% | 1.05% | 1.44% | Q3 2022 | Q4 2022 | 2 |
| TMH | TEAM HEALTH HOLDINGS INC | 1 | 1 | 0.50% | 0.93% | 1.37% | Q2 2013 | Q3 2015 | 2 |
| IART | INTEGRA LIFESCIENCES H... | 2 | 2 | 0.52% | 0.91% | 1.31% | Q1 2015 | Q2 2015 | 2 |
| PKI | PERKINELMER INC | 1 | 1 | 0.13% | 0.90% | 1.66% | Q2 2016 | Q4 2016 | 2 |
| CRVL | CORVEL CORP | 2 | 2 | 0.43% | 0.89% | 1.34% | Q2 2013 | Q3 2013 | 2 |
| LLY | LILLY ELI & CO | 1 | 1 | 0.47% | 0.86% | 1.26% | Q2 2015 | Q4 2019 | 2 |
| BNTX | BIONTECH SE | 1 | 1 | 0.28% | 0.84% | 1.41% | Q2 2020 | Q3 2021 | 2 |
| AMRX | AMNEAL PHARMACEUTICALS... | 2 | 2 | 0.76% | 0.83% | 0.90% | Q3 2018 | Q4 2018 | 2 |
| TKMR | TEKMIRA PHARMACEUTICAL... | 2 | 2 | 0.60% | 0.81% | 1.03% | Q1 2015 | Q2 2015 | 2 |
| EXEL | EXELIXIS INC | 2 | 2 | 0.39% | 0.77% | 1.15% | Q3 2013 | Q4 2013 | 2 |
| CLVS | CLOVIS ONCOLOGY INC | 1 | 1 | 0.34% | 0.76% | 1.18% | Q2 2017 | Q4 2018 | 2 |
| ALNY | ALNYLAM PHARMACEUTICAL... | 1 | 1 | 0.06% | 0.69% | 1.32% | Q2 2019 | Q3 2021 | 2 |
| ZGNX | ZOGENIX INC | 2 | 2 | 0.20% | 0.67% | 1.15% | Q3 2019 | Q4 2019 | 2 |
| ABC | AMERISOURCEBERGEN CORP | 1 | 1 | 0.53% | 0.67% | 0.81% | Q2 2014 | Q1 2015 | 2 |
| ZYME | ZYMEWORKS INC | 1 | 1 | 0.63% | 0.64% | 0.64% | Q1 2020 | Q3 2020 | 2 |
| CRIS | CURIS INC | 2 | 2 | 0.39% | 0.57% | 0.75% | Q4 2020 | Q1 2021 | 2 |
| STML | STEMLINE THERAPEUTICS INC | 2 | 2 | 0.49% | 0.56% | 0.64% | Q2 2019 | Q3 2019 | 2 |
| ARIA | ARIAD PHARMACEUTICALS INC | 2 | 2 | 0.43% | 0.54% | 0.66% | Q2 2014 | Q3 2014 | 2 |
| CMRX | CHIMERIX INC | 2 | 2 | 0.35% | 0.53% | 0.71% | Q2 2013 | Q3 2013 | 2 |
| ARYD | ARYA SCIENCES ACQU COR... | 2 | 2 | 0.43% | 0.48% | 0.53% | Q1 2021 | Q2 2021 | 2 |
| ADPT | ADAPTIVE BIOTECHNOLOGI... | 1 | 1 | 0.22% | 0.46% | 0.70% | Q2 2019 | Q2 2020 | 2 |
| IBB | ISHARES TR | 2 | 2 | 0.24% | 0.44% | 0.64% | Q1 2022 | Q2 2022 | 2 |
| MTD | METTLER TOLEDO INTERNA... | 1 | 1 | 0.16% | 0.41% | 0.66% | Q3 2013 | Q1 2018 | 2 |
| SRPT | SAREPTA THERAPEUTICS INC | 1 | 1 | 0.36% | 0.37% | 0.38% | Q3 2013 | Q3 2017 | 2 |
| Q | QUINTILES TRANSNATIO H... | 2 | 2 | 0.31% | 0.37% | 0.42% | Q1 2015 | Q2 2015 | 2 |
| RCUS | ARCUS BIOSCIENCES INC | 1 | 1 | 0.10% | 0.32% | 0.53% | Q1 2021 | Q3 2021 | 2 |
| MSAC | MEDICUS SCIENCES ACQUI... | 2 | 2 | 0.29% | 0.30% | 0.31% | Q2 2021 | Q3 2021 | 2 |
| CEMP | CEMPRA INC | 1 | 1 | 0.02% | 0.28% | 0.55% | Q4 2014 | Q3 2015 | 2 |
| ARYA SCIENCES ACQUISIT... | 2 | 2 | 0.21% | 0.24% | 0.26% | Q3 2021 | Q4 2021 | 2 | |
| PSNL | PERSONALIS INC | 2 | 2 | 0.16% | 0.24% | 0.32% | Q2 2019 | Q3 2019 | 2 |
| STXS | STEREOTAXIS INC | 2 | 2 | 0.20% | 0.21% | 0.22% | Q4 2021 | Q1 2022 | 2 |
| ICUI | ICU MED INC | 1 | 1 | 0.10% | 0.21% | 0.32% | Q3 2018 | Q1 2021 | 2 |
| CYAD | CELYAD SA | 2 | 2 | 0.17% | 0.19% | 0.20% | Q2 2015 | Q3 2015 | 2 |
| GHRS | GH RESEARCH PLC | 2 | 2 | 0.16% | 0.19% | 0.22% | Q2 2021 | Q3 2021 | 2 |
| VCYT | VERACYTE INC | 2 | 2 | 0.10% | 0.18% | 0.27% | Q3 2021 | Q4 2021 | 2 |
| NGM | NGM BIOPHARMACEUTICALS... | 2 | 2 | 0.17% | 0.18% | 0.20% | Q2 2019 | Q3 2019 | 2 |
| ACHN | ACHILLION PHARMACEUTIC... | 2 | 2 | 0.07% | 0.16% | 0.26% | Q3 2014 | Q4 2014 | 2 |
| HCP | HCP INC | 2 | 2 | 0.12% | 0.14% | 0.15% | Q2 2013 | Q3 2013 | 2 |
| PYXIS ONCOLOGY INC | 2 | 2 | 0.06% | 0.10% | 0.15% | Q4 2021 | Q1 2022 | 2 | |
| DICE THERAPEUTICS INC | 2 | 2 | 0.06% | 0.08% | 0.10% | Q3 2021 | Q4 2021 | 2 | |
| OREX | OREXIGEN THERAPEUTICS INC | 2 | 2 | 0.05% | 0.08% | 0.11% | Q2 2015 | Q3 2015 | 2 |
| JNCE | JOUNCE THERAPEUTICS INC | 2 | 2 | 0.07% | 0.07% | 0.07% | Q1 2021 | Q2 2021 | 2 |
| CPRX | CATALYST PHARMACEUTICA... | 2 | 2 | 0.06% | 0.07% | 0.08% | Q2 2015 | Q3 2015 | 2 |
| XOMA | XOMA CORP DEL | 2 | 2 | 0.03% | 0.06% | 0.09% | Q3 2014 | Q4 2014 | 2 |
| ATAI | ATAI LIFE SCIENCES NV | 2 | 2 | 0.05% | 0.05% | 0.06% | Q2 2021 | Q3 2021 | 2 |
| WMGIZ | WRIGHT MED GROUP INC | 2 | 2 | 0.01% | 0.04% | 0.08% | Q2 2014 | Q3 2014 | 2 |
| ANIK | ANIKA THERAPEUTICS INC | 2 | 2 | 0.02% | 0.03% | 0.04% | Q4 2020 | Q1 2021 | 2 |
| MREO | MEREO BIOPHARMA GROUP PLC | 2 | 2 | 0.02% | 0.02% | 0.02% | Q1 2021 | Q2 2021 | 2 |
| CMLTW | CM LIFE SCIENCES III INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q2 2021 | Q3 2021 | 2 |
| SPY | SPDR S&P 500 ETF TR | 1 | 1 | 10.94% | 10.94% | 10.94% | Q4 2018 | Q4 2018 | 1 |
| BXLT | BAXALTA INC | 1 | 1 | 6.38% | 6.38% | 6.38% | Q4 2015 | Q4 2015 | 1 |
| SRCL | STERICYCLE INC | 1 | 1 | 6.08% | 6.08% | 6.08% | Q3 2015 | Q3 2015 | 1 |
| VRX | VALEANT PHARMACEUTICAL... | 1 | 1 | 5.18% | 5.18% | 5.18% | Q4 2014 | Q4 2014 | 1 |
| WOOF | VCA INC | 1 | 1 | 3.88% | 3.88% | 3.88% | Q4 2016 | Q4 2016 | 1 |
| KEYS | KEYSIGHT TECHNOLOGIES INC | 1 | 1 | 3.85% | 3.85% | 3.85% | Q4 2014 | Q4 2014 | 1 |
| ELAN | ELANCO ANIMAL HEALTH INC | 1 | 1 | 3.78% | 3.78% | 3.78% | Q2 2019 | Q2 2019 | 1 |
| XBI | SPDR SER TR | 1 | 1 | 3.60% | 3.60% | 3.60% | Q1 2022 | Q1 2022 | 1 |
| WCG | WELLCARE HEALTH PLANS INC | 1 | 1 | 3.41% | 3.41% | 3.41% | Q4 2018 | Q4 2018 | 1 |
| ISRG | INTUITIVE SURGICAL INC | 1 | 1 | 3.16% | 3.16% | 3.16% | Q1 2014 | Q1 2014 | 1 |
| ENDP | ENDO INTL PLC | 1 | 1 | 3.14% | 3.14% | 3.14% | Q1 2014 | Q1 2014 | 1 |
| CBST | CUBIST PHARMACEUTICALS... | 1 | 1 | 3.07% | 3.07% | 3.07% | Q3 2013 | Q3 2013 | 1 |
| MJN | MEAD JOHNSON NUTRITION CO | 1 | 1 | 3.05% | 3.05% | 3.05% | Q4 2013 | Q4 2013 | 1 |
| ACRIVON THERAPEUTICS INC | 1 | 1 | 3.00% | 3.00% | 3.00% | Q4 2022 | Q4 2022 | 1 | |
| ACT | ACTAVIS INC | 1 | 1 | 2.89% | 2.89% | 2.89% | Q3 2013 | Q3 2013 | 1 |
| NKTR | NEKTAR THERAPEUTICS | 1 | 1 | 2.79% | 2.79% | 2.79% | Q2 2013 | Q2 2013 | 1 |
| MNST | MONSTER BEVERAGE CORP | 1 | 1 | 2.76% | 2.76% | 2.76% | Q2 2013 | Q2 2013 | 1 |
| BHC | BAUSCH HEALTH COS INC | 1 | 1 | 2.53% | 2.53% | 2.53% | Q1 2020 | Q1 2020 | 1 |
| B108PS | ACTAVIS PLC | 1 | 1 | 2.48% | 2.48% | 2.48% | Q3 2014 | Q3 2014 | 1 |
| ABT | ABBOTT LABS | 1 | 1 | 2.33% | 2.33% | 2.33% | Q4 2013 | Q4 2013 | 1 |
| MYL | MYLAN N V | 1 | 1 | 2.26% | 2.26% | 2.26% | Q1 2015 | Q1 2015 | 1 |
| HZNP | HORIZON PHARMA INC | 1 | 1 | 2.14% | 2.14% | 2.14% | Q2 2014 | Q2 2014 | 1 |
| SYNH | SYNEOS HEALTH INC | 1 | 1 | 2.08% | 2.08% | 2.08% | Q4 2020 | Q4 2020 | 1 |
| SYK | STRYKER CORP | 1 | 1 | 1.92% | 1.92% | 1.92% | Q1 2019 | Q1 2019 | 1 |
| BSX | BOSTON SCIENTIFIC CORP | 1 | 1 | 1.87% | 1.87% | 1.87% | Q2 2022 | Q2 2022 | 1 |
| EW | EDWARDS LIFESCIENCES CORP | 1 | 1 | 1.85% | 1.85% | 1.85% | Q2 2015 | Q2 2015 | 1 |
| CYH | COMMUNITY HEALTH SYS I... | 1 | 1 | 1.84% | 1.84% | 1.84% | Q2 2013 | Q2 2013 | 1 |
| ABMD | ABIOMED INC | 1 | 1 | 1.74% | 1.74% | 1.74% | Q4 2019 | Q4 2019 | 1 |
| SHPG | SHIRE PLC | 1 | 1 | 1.58% | 1.58% | 1.58% | Q2 2013 | Q2 2013 | 1 |
| MDT | MEDTRONIC PLC | 1 | 1 | 1.55% | 1.55% | 1.55% | Q4 2021 | Q4 2021 | 1 |
| HSP | HOSPIRA INC | 1 | 1 | 1.55% | 1.55% | 1.55% | Q2 2014 | Q2 2014 | 1 |
| AXSM | AXSOME THERAPEUTICS INC | 1 | 1 | 1.51% | 1.51% | 1.51% | Q4 2019 | Q4 2019 | 1 |
| EVHC | ENVISION HEALTHCARE HL... | 1 | 1 | 1.46% | 1.46% | 1.46% | Q2 2016 | Q2 2016 | 1 |
| INCY | INCYTE CORP | 1 | 1 | 1.45% | 1.45% | 1.45% | Q1 2014 | Q1 2014 | 1 |
| SGEN | SEATTLE GENETICS INC | 1 | 1 | 1.37% | 1.37% | 1.37% | Q1 2014 | Q1 2014 | 1 |
| TSRO | TESARO INC | 1 | 1 | 1.37% | 1.37% | 1.37% | Q1 2015 | Q1 2015 | 1 |
| PDCO | PATTERSON COMPANIES INC | 1 | 1 | 1.33% | 1.33% | 1.33% | Q1 2015 | Q1 2015 | 1 |
| ABBV | ABBVIE INC | 1 | 1 | 1.29% | 1.29% | 1.29% | Q1 2018 | Q1 2018 | 1 |
| UTHR | UNITED THERAPEUTICS CO... | 1 | 1 | 1.26% | 1.26% | 1.26% | Q3 2015 | Q3 2015 | 1 |
| ESRX | EXPRESS SCRIPTS HLDG CO | 1 | 1 | 1.15% | 1.15% | 1.15% | Q2 2017 | Q2 2017 | 1 |
| MDCO | MEDICINES CO | 1 | 1 | 1.13% | 1.13% | 1.13% | Q1 2019 | Q1 2019 | 1 |
| HZNP | HORIZON THERAPEUTICS P... | 1 | 1 | 1.13% | 1.13% | 1.13% | Q4 2020 | Q4 2020 | 1 |
| EXAS | EXACT SCIENCES CORP | 1 | 1 | 1.09% | 1.09% | 1.09% | Q2 2018 | Q2 2018 | 1 |
| CTLT | CATALENT INC | 1 | 1 | 1.08% | 1.08% | 1.08% | Q4 2020 | Q4 2020 | 1 |
| EVHC | ENVISION HEALTHCARE CORP | 1 | 1 | 1.06% | 1.06% | 1.06% | Q1 2018 | Q1 2018 | 1 |
| AGN | ALLERGAN PLC | 1 | 1 | 1.03% | 1.03% | 1.03% | Q3 2017 | Q3 2017 | 1 |
| PEN | PENUMBRA INC | 1 | 1 | 1.02% | 1.02% | 1.02% | Q4 2022 | Q4 2022 | 1 |
| MNKKQ | MALLINCKRODT PUB LTD CO | 1 | 1 | 1.00% | 1.00% | 1.00% | Q3 2017 | Q3 2017 | 1 |
| AVTR | AVANTOR INC | 1 | 1 | 0.98% | 0.98% | 0.98% | Q4 2021 | Q4 2021 | 1 |
| ARNA | ARENA PHARMACEUTICALS INC | 1 | 1 | 0.93% | 0.93% | 0.93% | Q3 2020 | Q3 2020 | 1 |
| RAIN | RAIN ONCOLOGY INC | 1 | 1 | 0.88% | 0.88% | 0.88% | Q4 2022 | Q4 2022 | 1 |
| SLXP | SALIX PHARMACEUTICALS INC | 1 | 1 | 0.88% | 0.88% | 0.88% | Q3 2013 | Q3 2013 | 1 |
| CVS | CVS HEALTH CORP | 1 | 1 | 0.87% | 0.87% | 0.87% | Q1 2019 | Q1 2019 | 1 |
| DXCM | DEXCOM INC | 1 | 1 | 0.86% | 0.86% | 0.86% | Q2 2016 | Q2 2016 | 1 |
| SHPG | SHIRE PLC | 1 | 1 | 0.86% | 0.86% | 0.86% | Q4 2013 | Q4 2013 | 1 |
| PTCT | PTC THERAPEUTICS INC | 1 | 1 | 0.84% | 0.84% | 0.84% | Q3 2013 | Q3 2013 | 1 |
| PFE | PFIZER INC | 1 | 1 | 0.84% | 0.84% | 0.84% | Q2 2019 | Q2 2019 | 1 |
| RARE | ULTRAGENYX PHARMACEUTI... | 1 | 1 | 0.84% | 0.84% | 0.84% | Q1 2021 | Q1 2021 | 1 |
| AEGR | AEGERION PHARMACEUTICA... | 1 | 1 | 0.83% | 0.83% | 0.83% | Q1 2014 | Q1 2014 | 1 |
| ANAC | ANACOR PHARMACEUTICALS... | 1 | 1 | 0.83% | 0.83% | 0.83% | Q3 2015 | Q3 2015 | 1 |
| TTPH | TETRAPHASE PHARMACEUTI... | 1 | 1 | 0.82% | 0.82% | 0.82% | Q1 2015 | Q1 2015 | 1 |
| ALNY | ALNYLAM PHARMACEUTICAL... | 1 | 1 | 0.81% | 0.81% | 0.81% | Q1 2014 | Q1 2014 | 1 |
| MYL | MYLAN INC | 1 | 1 | 0.79% | 0.79% | 0.79% | Q4 2013 | Q4 2013 | 1 |
| AIRM | AIR METHODS CORP | 1 | 1 | 0.79% | 0.79% | 0.79% | Q2 2013 | Q2 2013 | 1 |
| V107SC | WELLPOINT INC | 1 | 1 | 0.78% | 0.78% | 0.78% | Q3 2013 | Q3 2013 | 1 |
| NBIX | NEUROCRINE BIOSCIENCES... | 1 | 1 | 0.77% | 0.77% | 0.77% | Q2 2016 | Q2 2016 | 1 |
| SILK | SILK RD MED INC | 1 | 1 | 0.73% | 0.73% | 0.73% | Q4 2022 | Q4 2022 | 1 |
| SHC | SOTERA HEALTH CO | 1 | 1 | 0.71% | 0.71% | 0.71% | Q1 2021 | Q1 2021 | 1 |
| SWAV | SHOCKWAVE MED INC | 1 | 1 | 0.69% | 0.69% | 0.69% | Q3 2022 | Q3 2022 | 1 |
| XBI | SPDR SER TR | 1 | 1 | 0.65% | 0.65% | 0.65% | Q1 2020 | Q1 2020 | 1 |
| IRTC | IRHYTHM TECHNOLOGIES INC | 1 | 1 | 0.64% | 0.64% | 0.64% | Q1 2019 | Q1 2019 | 1 |
| GMED | GLOBUS MED INC | 1 | 1 | 0.63% | 0.63% | 0.63% | Q4 2016 | Q4 2016 | 1 |
| LGVU | LONGVIEW ACQUISITION C... | 1 | 1 | 0.62% | 0.62% | 0.62% | Q1 2021 | Q1 2021 | 1 |
| ALLO | ALLOGENE THERAPEUTICS INC | 1 | 1 | 0.62% | 0.62% | 0.62% | Q1 2021 | Q1 2021 | 1 |
| XLRN | ACCELERON PHARMA INC | 1 | 1 | 0.61% | 0.61% | 0.61% | Q4 2019 | Q4 2019 | 1 |
| ALXN | ALEXION PHARMACEUTICAL... | 1 | 1 | 0.58% | 0.58% | 0.58% | Q1 2020 | Q1 2020 | 1 |
| CLDX | CELLDEX THERAPEUTICS I... | 1 | 1 | 0.57% | 0.57% | 0.57% | Q3 2013 | Q3 2013 | 1 |
| TVTX | TRAVERE THERAPEUTICS INC | 1 | 1 | 0.55% | 0.55% | 0.55% | Q1 2021 | Q1 2021 | 1 |
| GMAB | GENMAB A S | 1 | 1 | 0.53% | 0.53% | 0.53% | Q3 2019 | Q3 2019 | 1 |
| P103PS | NPS PHARMACEUTICALS INC | 1 | 1 | 0.53% | 0.53% | 0.53% | Q3 2014 | Q3 2014 | 1 |
| JUNO | JUNO THERAPEUTICS INC | 1 | 1 | 0.53% | 0.53% | 0.53% | Q1 2017 | Q1 2017 | 1 |
| THC | TENET HEALTHCARE CORP | 1 | 1 | 0.52% | 0.52% | 0.52% | Q1 2015 | Q1 2015 | 1 |
| SRPT | SAREPTA THERAPEUTICS INC | 1 | 1 | 0.51% | 0.51% | 0.51% | Q3 2013 | Q3 2013 | 1 |
| OXBT | OXYGEN BIOTHERAPEUTICS... | 1 | 1 | 0.50% | 0.50% | 0.50% | Q1 2014 | Q1 2014 | 1 |
| HMSY | HMS HLDGS CORP | 1 | 1 | 0.49% | 0.49% | 0.49% | Q4 2019 | Q4 2019 | 1 |
| EXEL | EXELIXIS INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q1 2014 | Q1 2014 | 1 |
| ELGX | ENDOLOGIX INC | 1 | 1 | 0.47% | 0.47% | 0.47% | Q1 2015 | Q1 2015 | 1 |
| BAX | BAXTER INTL INC | 1 | 1 | 0.47% | 0.47% | 0.47% | Q2 2018 | Q2 2018 | 1 |
| IOVA | IOVANCE BIOTHERAPEUTIC... | 1 | 1 | 0.46% | 0.46% | 0.46% | Q1 2019 | Q1 2019 | 1 |
| ARWR | ARROWHEAD RESH CORP | 1 | 1 | 0.44% | 0.44% | 0.44% | Q1 2014 | Q1 2014 | 1 |
| WWAVB | WHITEWAVE FOODS CO | 1 | 1 | 0.43% | 0.43% | 0.43% | Q2 2013 | Q2 2013 | 1 |
| CCE | COCA COLA ENTERPRISES ... | 1 | 1 | 0.43% | 0.43% | 0.43% | Q3 2013 | Q3 2013 | 1 |
| BOTA | BIOTA PHARMACEUTIALS INC | 1 | 1 | 0.42% | 0.42% | 0.42% | Q1 2014 | Q1 2014 | 1 |
| NEO | NEOGENOMICS INC | 1 | 1 | 0.42% | 0.42% | 0.42% | Q3 2022 | Q3 2022 | 1 |
| ESRX | EXPRESS SCRIPTS HLDG CO | 1 | 1 | 0.42% | 0.42% | 0.42% | Q1 2014 | Q1 2014 | 1 |
| VXX | BARCLAYS BK PLC | 1 | 1 | 0.42% | 0.42% | 0.42% | Q3 2016 | Q3 2016 | 1 |
| IONS | IONIS PHARMACEUTICALS INC | 1 | 1 | 0.41% | 0.41% | 0.41% | Q1 2019 | Q1 2019 | 1 |
| DYAX | DYAX CORP | 1 | 1 | 0.39% | 0.39% | 0.39% | Q1 2015 | Q1 2015 | 1 |
| ARCT | ARCTURUS THERAPEUTICS ... | 1 | 1 | 0.34% | 0.34% | 0.34% | Q3 2020 | Q3 2020 | 1 |
| FATE | FATE THERAPEUTICS INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q3 2021 | Q3 2021 | 1 |
| SGMO | SANGAMO BIOSCIENCES INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q1 2014 | Q1 2014 | 1 |
| ARAY | ACCURAY INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q1 2015 | Q1 2015 | 1 |
| GNFT | GENFIT S A | 1 | 1 | 0.32% | 0.32% | 0.32% | Q1 2019 | Q1 2019 | 1 |
| RPTP | RAPTOR PHARMACEUTICAL ... | 1 | 1 | 0.31% | 0.31% | 0.31% | Q2 2016 | Q2 2016 | 1 |
| AMWL | AMERICAN WELL CORP | 1 | 1 | 0.30% | 0.30% | 0.30% | Q3 2020 | Q3 2020 | 1 |
| INNV | INNOVAGE HLDG CORP | 1 | 1 | 0.30% | 0.30% | 0.30% | Q1 2021 | Q1 2021 | 1 |
| DGX | QUEST DIAGNOSTICS INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2015 | Q1 2015 | 1 |
| MSACU | MEDICUS SCIENCES ACQUI... | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2021 | Q1 2021 | 1 |
| AMN | AMN HEALTHCARE SERVICE... | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2016 | Q3 2016 | 1 |
| CCXI | CHEMOCENTRYX INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q2 2022 | Q2 2022 | 1 |
| ALGN | ALIGN TECHNOLOGY INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q2 2022 | Q2 2022 | 1 |
| CVET | COVETRUS INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q4 2019 | Q4 2019 | 1 |
| SDC | SMILEDIRECTCLUB INC | 1 | 1 | 0.23% | 0.23% | 0.23% | Q2 2020 | Q2 2020 | 1 |
| MDCO | MEDICINES CO | 1 | 1 | 0.23% | 0.23% | 0.23% | Q4 2019 | Q4 2019 | 1 |
| FOLD | AMICUS THERAPEUTICS INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q4 2020 | Q4 2020 | 1 |
| XOMA | XOMA CORP DEL | 1 | 1 | 0.22% | 0.22% | 0.22% | Q3 2014 | Q3 2014 | 1 |
| CMLT | CM LIFE SCIENCES III INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q2 2021 | Q2 2021 | 1 |
| OHPAU | ORION ACQUISITION CORP | 1 | 1 | 0.21% | 0.21% | 0.21% | Q1 2021 | Q1 2021 | 1 |
| NVAX | NOVAVAX INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q2 2021 | Q2 2021 | 1 |
| DERM | DERMIRA INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q4 2019 | Q4 2019 | 1 |
| CERT | CERTARA INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q4 2020 | Q4 2020 | 1 |
| ISEE | IVERIC BIO INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q3 2022 | Q3 2022 | 1 |
| CLDX | CELLDEX THERAPEUTICS I... | 1 | 1 | 0.19% | 0.19% | 0.19% | Q1 2021 | Q1 2021 | 1 |
| AXNX | AXONICS INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q4 2021 | Q4 2021 | 1 |
| TIL | INSTIL BIO INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q1 2021 | Q1 2021 | 1 |
| ATHA | ATHIRA PHARMA INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q3 2020 | Q3 2020 | 1 |
| HMA | HEALTH MGMT ASSOC INC NEW | 1 | 1 | 0.16% | 0.16% | 0.16% | Q4 2013 | Q4 2013 | 1 |
| PODD | INSULET CORP | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2022 | Q2 2022 | 1 |
| PDCO | PATTERSON COMPANIES INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2018 | Q2 2018 | 1 |
| KERX | KERYX BIOPHARMACEUTICA... | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2014 | Q4 2014 | 1 |
| FOLD | AMICUS THERAPEUTICS INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2016 | Q4 2016 | 1 |
| LEGN | LEGEND BIOTECH CORP | 1 | 1 | 0.13% | 0.13% | 0.13% | Q2 2020 | Q2 2020 | 1 |
| IPCM | IPC HEALTHCARE INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q2 2015 | Q2 2015 | 1 |
| FSII | FS DEVELOPMENT CORP II | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2021 | Q1 2021 | 1 |
| CBAY | CYMABAY THERAPEUTICS INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2019 | Q1 2019 | 1 |
| FUSN | FUSION PHARMACEUTICALS... | 1 | 1 | 0.11% | 0.11% | 0.11% | Q2 2020 | Q2 2020 | 1 |
| DTIL | PRECISION BIOSCIENCES INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q1 2019 | Q1 2019 | 1 |
| CYT | CYTEIR THERAPEUTICS INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2021 | Q2 2021 | 1 |
| DYN | DYNE THERAPEUTICS INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q3 2020 | Q3 2020 | 1 |
| AKUS | AKOUOS INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q2 2020 | Q2 2020 | 1 |
| DAWN | DAY ONE BIOPHARMACEUTI... | 1 | 1 | 0.09% | 0.09% | 0.09% | Q2 2021 | Q2 2021 | 1 |
| GLUE | MONTE ROSA THERAPEUTIC... | 1 | 1 | 0.09% | 0.09% | 0.09% | Q2 2021 | Q2 2021 | 1 |
| GBIO | GENERATION BIO CO | 1 | 1 | 0.09% | 0.09% | 0.09% | Q2 2020 | Q2 2020 | 1 |
| FNCH | FINCH THERAPEUTICS GRO... | 1 | 1 | 0.09% | 0.09% | 0.09% | Q1 2021 | Q1 2021 | 1 |
| RMTI | ROCKWELL MED INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2014 | Q1 2014 | 1 |
| HCN | HEALTH CARE REIT INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2013 | Q2 2013 | 1 |
| CMIIU | CM LIFE SCIENCES II INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2021 | Q1 2021 | 1 |
| OPHT | OPHTHOTECH CORP | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2015 | Q1 2015 | 1 |
| MRTX | MIRATI THERAPEUTICS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2021 | Q3 2021 | 1 |
| OM | OUTSET MED INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q3 2020 | Q3 2020 | 1 |
| KPTI | KARYOPHARM THERAPEUTIC... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2019 | Q1 2019 | 1 |
| AXLA | AXCELLA HEALTH INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2019 | Q2 2019 | 1 |
| PROCEPT BIOROBOTICS CORP | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2021 | Q3 2021 | 1 | |
| RNA | AVIDITY BIOSCIENCES INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2020 | Q2 2020 | 1 |
| AVIR | ATEA PHARMACEUTICALS INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2021 | Q3 2021 | 1 |
| ELEV | ELEVATION ONCOLOGY INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2021 | Q2 2021 | 1 |
| BLCM | BELLICUM PHARMACEUTICA... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2014 | Q4 2014 | 1 |
| GLMD | GALMED PHARMACEUTICALS... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2014 | Q1 2014 | 1 |
| KIN | KINDRED BIOSCIENCES INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2021 | Q1 2021 | 1 |
| CNTB | CONNECT BIOPHARMA HLDG... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2021 | Q1 2021 | 1 |
| UHT | UNIVERSAL HEALTH RLTY ... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q2 2013 | Q2 2013 | 1 |
| OMER | OMEROS CORP | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2021 | Q1 2021 | 1 |
| HLXA | HELIX ACQUISITION CORP | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2021 | Q1 2021 | 1 |
| LENS | PRESBIA PLC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2015 | Q1 2015 | 1 |
| BCTG | BCTG ACQUISITION CORP | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2021 | Q1 2021 | 1 |
| BBIO | BRIDGEBIO PHARMA INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2021 | Q4 2021 | 1 |
Download | |||||||||
The securities at the top of the list , including HCA HOLDINGS INC, ZIMMER HLDGS INC, and DANAHER CORPORATION, are the highest-conviction holdings of HealthCor Management, L.P..
The conviction is calculated by counting the number of quarters a security has been reported by HealthCor Management, L.P.. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that HealthCor Management, L.P. owns currently or has owned in the past.